Analyst firms · BofA Securities · ARDT
BofA Securities ARDT price target and rating history
Ardent Health Inc. (ARDT) · Health Care
BofA Securities rates Ardent Health Inc. (ARDT) Underperform with a $14.60 price target, as of its latest action on Jul 16, 2025. It has published 3 rating actions on ARDT since August 2024, including 0 upgrades and 2 downgrades.
- Current rating
- Underperform
- Price target
- $14.60
- Median target, all firms
- Too few
- Actions on ARDT
- 3
BofA Securities price target on ARDT
Every BofA Securities rating on ARDT
- Jul 16, 2025
- Nov 6, 2024
- Aug 12, 2024
How other firms rate ARDT
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| BMO Capital Markets | Market Perform | $11 | Sep 23, 2026 |
| KeyBanc Capital Markets | Sector Weight | Nov 17, 2025 | |
| Morgan Stanley | Equal-Weight | Nov 14, 2025 |
Questions about BofA Securities and ARDT
- What is BofA Securities's price target for ARDT?
- BofA Securities's latest stated price target for Ardent Health Inc. (ARDT) is $14.60, from its action on Jul 16, 2025.
- What is BofA Securities's rating on ARDT?
- BofA Securities rates ARDT Underperform, a bearish rating, as of Jul 16, 2025.
- When did BofA Securities last change its view on ARDT?
- On Jul 16, 2025, BofA Securities downgrades to Underperform from Neutral, price target $14.60.
All BofA Securities ratingsARDT news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.